News

June 21, 2011 – The Heart Hospital of Austin, a physician-led hospital specializing in the diagnosis and treatment of cardiovascular disease in Austin, Texas, recently adopted the Philips iE33...
June 21, 2011 – The St. Francis Heart Center in Indianapolis, Ind., announced that it has performed the first post-U.S. Food and Drug Administration (FDA) approval surgery in the United States using...
June 14, 2011 – The first successful Chinese implants of the Edwards SAPIEN XT valve were performed in May.
June 10, 2011 - A U.S. Food and Drug Administration (FDA) advisory panel is scheduled to review Edwards Lifesciences’ premarket approval (PMA) application for the Sapien transcatheter heart valve on...
May 23, 2011 - A presentation about transcatheter aortic valve implantation (TAVI) at EuroPCR 2011 confirmed positive outcomes in patients receiving the CoreValve System from Medtronic Inc., across...
May 20, 2011 - Edwards Lifesciences Corporation announced that clinicians continued to achieve successful one-year outcomes in high-risk or inoperable patients undergoing transcatheter aortic valve...
May 19, 2011 – New clinical data presented today at EuroPCR 2011 demonstrate immediate and long-term health-related quality-of-life (HRQoL) benefits for patients receiving the Medtronic CoreValve...
May 9, 2011 — John Webb, M.D., FSCAI, has traveled the globe teaching fellow physicians how to repair or replace faulty heart valves using minimally invasive techniques. In a keynote Founders’...
May 4, 2011 -- Two new clinical studies will use the Carillon Mitral Contour System, an investigational device for percutaneous treatment of functional mitral regurgitation (FMR).

April 22, 2011 – The U.S. Food and Drug Administration (FDA) has cleared the Trifecta valve, by St. Jude Medical. The valve, a clinically-proven replacement for diseased, damaged or malfunctioning...

April 11, 2011 — The following is a roundup of key news and trial data that came out of the American College of Cardiology (ACC) 2011 Scientific Session in New Orleans last week. ...

The transcatheter MitraClip mitral valve repair system continues to compare favorably with conventional open-heart surgery for treatment of select patients with mitral regurgitation. The findings...

April 6, 2011 – Data from the EVEREST II study show that patients with significant mitral regurgitation (MR) continue to show benefits from treatment with a catheter-based valve-clip system at one...

April 6, 2011 – Development of a novel embolic protection device designed for use during transcatheter aortic valve implantation (TAVI) procedures received $10.5 million in funding. SMT Research...

April 5, 2011 – Death rates are similar at one year for a catheter-based aortic valve replacement procedure and conventional surgery in older high-risk patients.

April 4, 2011 – A new system for treating mitral regurgitation (MR) has been launched in Australia. The MitraClip device, by Abbott, has received Therapeutic Goods Administration (TGA) approval...

March 29, 2011 – One-year outcomes from Cohort A of the PARTNER trial will be presented April 3 at the American College of Cardiology’s (ACC) 60th Annual Scientific Session and Expo in New Orleans...

March 15, 2011 – A new tricuspid ring for the treatment of tricuspid valve disease is approved for use in the United States, Europe and several other countries. The Contour 3D Annuloplasty Ring,...

March 14, 2011 – Expanding its transcatheter valve accessories with the addition of an aortic embolic protection device, Edwards Lifesciences Corp. completed the acquisition of Embrella...

March 14, 2011 – Sorin Group has reached a major milestone with the 100,000th MitroFlow Aortic Pericardial Heart Valve implantation worldwide.